摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-hydroxy-2-deoxy-2-thiocoumarin | 70685-46-0

中文名称
——
中文别名
——
英文名称
4-hydroxy-2-deoxy-2-thiocoumarin
英文别名
4-hydroxy-2H-chromen-2-thione;4-hydroxy-2-thiocoumarin;4-hydroxythionecoumarin;4-hydroxythiocoumarin
4-hydroxy-2-deoxy-2-thiocoumarin化学式
CAS
70685-46-0
化学式
C9H6O2S
mdl
——
分子量
178.211
InChiKey
UYTWKZKDNIKGAC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.87
  • 重原子数:
    12.0
  • 可旋转键数:
    0.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    33.37
  • 氢给体数:
    1.0
  • 氢受体数:
    3.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-hydroxy-2-deoxy-2-thiocoumarin叔丁基过氧化氢间氯过氧苯甲酸 作用下, 以 二氯甲烷二甲基亚砜 为溶剂, 反应 3.0h, 生成 2-((1H-indol-3-yl)sulfonyl)-4H-chromen-4-one
    参考文献:
    名称:
    氧化交叉脱氢偶联反应从4-羟基-2H-色烯-2-硫酮和吲哚合成3-硫基吲哚衍生物及其部分砜衍生物的抗增殖活性研究
    摘要:
    通过采用氧化交叉脱氢偶联反应,由 4-羟基硫代香豆素和吲哚合成了一类新型的 3-硫基吲哚衍生物。对六种砜类衍生物进行了靶点预测和对接研究,并选择了四种砜类衍生物进行进一步的体外研究。图 1. 3-磺基吲哚和一些砜衍生物的合成。
    DOI:
    10.1016/j.bioorg.2023.106900
  • 作为产物:
    描述:
    4-羟基香豆素劳森试剂 作用下, 以 甲苯 为溶剂, 以85%的产率得到4-hydroxy-2-deoxy-2-thiocoumarin
    参考文献:
    名称:
    Fahmy, A. A.; Hafez, T. S.; El-Farargy, A. F., Phosphorus, Sulfur and Silicon and the Related Elements, 1991, vol. 57, # 3/4, p. 211 - 215
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Cyclization reactions of coumarin derivatives: Chemo- and regioselectivity effects of oxygen/sulfur isosteric replacement
    作者:Giovanni Palmisano、Lucio Toma、Rita Annunziata、Silvia Tagliapietra、Alessandro Barge、Giancarlo Cravotto
    DOI:10.1002/jhet.5570440221
    日期:2007.3
    We synthesized several sulfur isosters of ferulenol and related prenylcoumarins from Ferula communis preliminary to finding whether the antitubercular activity of these natural compounds might be dissociated from their antithrombin activity. Direct thionation of ferprenine, an instance of “diversity-oriented” synthesis, yielded a mixture of three thiocoumarin derivatives. When 4-hydroxy-2-deoxy-2-thiocoumarin
    我们从Ferula communis合成了几种阿魏醇和相关异戊二烯香豆素等排体初步发现这些天然化合物的抗结核活性是否可能与其抗凝血酶活性分离。所谓的“以多样性为导向”合成的实例是直接对丁胺进行硫磺化,生成了三种香豆素生物的混合物。当4-羟基-2--2-香豆素与法呢醛和其他α,β-不饱和醛反应时,位置2的等位-取代令人惊讶地引起串联Knoevenagel-电环反应中的区域化学转化,普遍提供线性加合物。广泛调查了各种替代的食用油,突显出Knoevenagel和Michael加成之间的竞争。通过考虑空间和电子因素以及与催化剂形成复合物的能量计算,使该结果合理化。
  • RODENTICIDAL COMPOUND, COMPOSITION INCLUDING SAME AND USE FOR COMBATING RODENT PESTS
    申请人:Caruel Herve
    公开号:US20140187625A1
    公开(公告)日:2014-07-03
    A novel compound obtained from molecules of the coumarin family, which exhibits rodenticidal activity. Also, compositions which incorporate such compounds and the use thereof for combating rodent pests.
    一种从香豆素家族分子中获得的新化合物,具有杀鼠活性。此外,还包括含有这种化合物的组合物及其用于对抗啮齿类害虫的用途。
  • Formal [3+3] cycloaddition reaction of 4-hydroxythiocoumarin to 4Н-chromene-3-carbaldehydes: synthesis of thiochromeno[3',4':5,6]pyrano[2,3-b]chromen-6-ones
    作者:Irina A. Semenova、Dmitry V. Osipov、Yulia V. Popova、Vitaly A. Osyanin、Oleg P. Demidov、Yuri N. Klimochkin
    DOI:10.1007/s10593-020-02801-6
    日期:2020.9
    A cascade reaction of 4-hydroxythiocoumarin and 4Н-chromene-3-carbaldehydes was developed, consisting of Knoevenagel condensation and oxa-6π electrocyclization in the presence of ammonium acetate as catalyst. A series of polycyclic acetals containing a fused thiocoumarin moiety were obtained.
    4- hydroxythiocoumarin和4所述的级联反应Н色-3- carbaldehydes被开发,在乙酸铵的存在下作为催化剂由Knoevenagel缩合和杂- 6πelectrocyclization的。获得一系列含有稠合的香豆素部分的多环缩醛
  • [EN] DNA-PK INHIBITORS<br/>[FR] INHIBITEURS D'ADN-PK
    申请人:CANCER REC TECH LTD
    公开号:WO2003024949A1
    公开(公告)日:2003-03-27
    The invention relates to the use of compounds of formula (I) and isomers, salts, solvates, chemically protected forms, and prodrugs thereof, in the preparation of a medicament for inhibiting the activity of DNA-PK, wherein R?1 and R2¿ are independently hydrogen, an optionally substituted C¿1-7? alkyl group, C3-20 heterocyclyl group, or C5-20 aryl group, or may together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring having from 4 to 8 ring atoms; X and Y are selected from CR?4¿ and O, O and CR'4 and NR'4 and N, where the unsaturation is in the appropriate place in the ring, and where one of R?3 and R4 or R'4¿ is an optionally substituted C¿3-20? heteroaryl or C5-20 aryl group, and the other of R?3 and R4 or R'4¿ is H, or R?3 and R4 or R'4¿ together are -A-B-, which collectively represent a fused optionally substituted aromatic ring. The compounds also selectively inhibit the activity of DNA-PK compared to PI 3-kinase and/or ATM.
    本发明涉及使用式(I)化合物及其异构体、盐、溶剂合物、化学保护形式和前药,在制备用于抑制DNA-PK活性的药物中使用,其中R?1和R2¿分别为、可选取代的C¿1-7?烷基、C3-20杂环基或C5-20芳基,或者可以与它们连接的原子一起形成具有4到8个环原子的可选取代杂环环;X和Y从CR?4¿和O、O和CR'4和NR'4和N中选取,其中不饱和度在环中适当位置,其中R?3和R4或R'4¿中的一个为可选取代的C¿3-20?杂芳基或C5-20芳基,而另一个为H,或者R?3和R4或R'4¿一起是-A-B-,它们共同代表一个融合的可选取代芳香环。这些化合物还比PI 3-激酶和/或ATM选择性地抑制DNA-PK活性。
  • Dna-pk inhibitors
    申请人:——
    公开号:US20040192687A1
    公开(公告)日:2004-09-30
    The invention relates to the use of compounds of formula (I) and isomers, salts, solvates, chemically protected forms, and prodrugs thereof, in the preparation of a medicament for inhibiting the activity of DNA-PK, wherein R 1 and R 2 are independently hydrogen, an optionally substituted C 1-7 alkyl group, C 3-20 heterocyclyl group, or C 5-20 aryl group, or may together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring having from 4 to 8 ring atoms; X and Y are selected from CR 4 and O, O and CR′ 4 and NR″ 4 and N, where the unsaturation is in the appropriate place in the ring, and where one of R 3 and R 4 or R′ 4 is an optionally substituted C 3-20 heteroaryl or C 5-20 aryl group, and the other of R 3 and R 4 or R′ 4 is H, or R 3 and R 4 or R″ 4 together are —A—B—, which collectively represent a fused optionally substituted aromatic ring. The compounds also selectively inhibit the activity of DNA-PK compared to PI 3-kinase and/or ATM. 1
    本发明涉及使用式(I)化合物及其异构体、盐、溶剂合物、化学保护形式及其前药,在制备抑制DNA-PK活性的药物方面使用。其中,R1和R2分别为、可选取代的C1-7烷基、C3-20杂环基或C5-20芳基,或者与它们连接的原子一起形成含有4到8个环原子的可选取代杂环环;X和Y从CR4和O、O和CR'4以及NR"4和N中选择,其中不饱和度在环中适当位置,且R3和R4或R'4中的一个为可选取代的C3-20杂芳基或C5-20芳基,而另一个为,或者R3和R4或R"4一起为-A-B-,它们共同表示一个融合的可选取代芳香环。这些化合物与PI 3-激酶和/或ATM相比,也具有选择性抑制DNA-PK活性的作用。
查看更多